• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 234-248 of 295 results

1010 Exhibit: PDR Aczone Gel 5%

Document IPR2019-00207, No. 1010-9 Exhibit - PDR Aczone Gel 5% (P.T.A.B. Nov. 6, 2018)

cite Cite Document
Analyze

1051 Exhibit: December 2010 IIG Database

Document IPR2019-00207, No. 1051-112 Exhibit - December 2010 IIG Database (P.T.A.B. Nov. 1, 2019)

cite Cite Document
Analyze

2052 Exhibit: Exhibit 2052 EU DGME 2010

Document IPR2019-00207, No. 2052-83 Exhibit - Exhibit 2052 EU DGME 2010 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2058 Exhibit: Exhibit 2058 Curriculum Vitae of Dr David Osborne

Document IPR2019-00207, No. 2058-89 Exhibit - Exhibit 2058 Curriculum Vitae of Dr David Osborne (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2022 Exhibit: Exhibit 2022 Kircik 2011

Document IPR2019-00207, No. 2022-53 Exhibit - Exhibit 2022 Kircik 2011 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2043 Exhibit: Exhibit 2043 Aczone 5% Clinical Pharmacol Biopharmaceutics Review

Document IPR2019-00207, No. 2043-74 Exhibit - Exhibit 2043 Aczone 5% Clinical Pharmacol Biopharmaceutics Review (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2059 Exhibit: Exhibit 2059 Gamble et al 2012

Document IPR2019-00207, No. 2059-90 Exhibit - Exhibit 2059 Gamble et al 2012 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2044 Exhibit: Exhibit 2044 Aczone 5 Percent Prescribing Information

Document IPR2019-00207, No. 2044-75 Exhibit - Exhibit 2044 Aczone 5 Percent Prescribing Information (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2060 Exhibit: Exhibit 2060 Heffernan et al 2007

Document IPR2019-00207, No. 2060-91 Exhibit - Exhibit 2060 Heffernan et al 2007 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2015 Exhibit: Exhibit 2015 Draelos et al 2007

Document IPR2019-00207, No. 2015-46 Exhibit - Exhibit 2015 Draelos et al 2007 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2046 Exhibit: Exhibit 2046 FDA approval letter dated 3142008

Document IPR2019-00207, No. 2046-77 Exhibit - Exhibit 2046 FDA approval letter dated 3142008 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2035 Exhibit: Exhibit 2035 Thiboutot et al 2008

Document IPR2019-00207, No. 2035-66 Exhibit - Exhibit 2035 Thiboutot et al 2008 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2017 Exhibit: Exhibit 2017 Ghods et al 2010

Document IPR2019-00207, No. 2017-48 Exhibit - Exhibit 2017 Ghods et al 2010 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2057 Exhibit: Exhibit 2057 Osborne Decl ISO Patent Owners Response

Document IPR2019-00207, No. 2057-88 Exhibit - Exhibit 2057 Osborne Decl ISO Patent Owners Response (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2061 Exhibit: Exhibit 2061 Marcinkiewicz et al 2008

Document IPR2019-00207, No. 2061-92 Exhibit - Exhibit 2061 Marcinkiewicz et al 2008 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 16 17 18 19 20 ... >>